To make informed decisions about reopening and resuming “business as usual” during the COVID-19 pandemic, we need reliable, well-protected information about who has been infected and who they’ve been in contact with since.
Mobile apps and modern disease surveillance technology are paramount during this time—and so is protecting consumers’ privacy. Get insights and examples to help you make the best decisions about contact tracing and other approaches to combat COVID-19 from experts in healthcare, privacy and security, and public policy.
- Describe health innovations for contact tracing versus telco or remote monitoring/surveillance and immunity passporting
- Explain the cultural and ethical policy considerations in the use of mobile contact tracing technologies
- Provide an overview of the supporting policy principles guided by HIPAA and GDPR; flexibilities provided to local authorities on how to collect, store and share COVID-19 app data; and opt-in/opt-out consumer safeguards
- Lee Kim, JD, CISSP, CIPP, Director, Privacy & Security/Thought Advisory; Interim Senior Counsel; Data Protection Officer; HIMSS
- Darren Larsen, MD, Chief Medical Officer, OntarioMD; Lecturer, Institute for Health Policy Management and Evaluation, University of Toronto
- Aaron Miri, MBA, CHCIO, FHIMSS , Chief Information Officer, Dell Medical School & UT Health Austin
- Jennifer Stoll, Executive Vice President, Government Relations and Public Affairs, OCHIN; Member, HIMSS Public Policy Committee
The views and opinions expressed in this content or by commenters are those of the author and do not necessarily reflect the official policy or position of HIMSS or its affiliates.